Introduction

Cancer initiation and progression involves complex processes that cannot be modelled completely using conventional 2D cultures of tumour cells. Integrated multidisciplinary efforts have led to the development of a wide range of novel approaches involving 3D culture, organoids, bioengineered systems, and in vivo models that more accurately reflect the biochemical, spatial and mechanical properties of tumours in their tissue environment.  

Following four highly successful in-person editions, this virtual conference will focus on the next generation of cancer models and emerging topics in the areas of cell architecture, mechanobiology, the immune microenvironment, intravital imaging and high-content analysis for cancer therapeutics. The conference format is designed to encourage networking optimized for our virtual platform. 

Who should attend?

Faculty, postdocs, and graduate students interested in the techniques and applications of next generation cancer models at the intersection of cancer biology, engineering, and drug development.   

Industry scientists interested in identifying promising platforms for drug discovery and targets for novel therapies. 

Topics to be covered

• Cell adhesion, mechanics, migration and survival 
• Imaging cancer invasion in 3D culture and in vivo  
• 3D in vitro systems for drug development and clinical applications  
• Intercellular interactions and the immune microenvironment 

Scientific Programme Committee

• Emmanuel Donnadieu, Institut Cochin, France
• Andrew Ewald, Johns Hopkins School of Medicine, USA
• Peter Friedl, Radboud UMC, Netherlands
• Henriëtte Lans, MIMETAS, Netherlands
• Valerie Weaver, UCSF, USA

Contact

If you have any queries that are not answered on this webpage, please contact us using the details below.

Claire Sullivan
Conference Officer
claire.sullivan@eacr.org

Sign-up for updates